4Niederman MS, Mandell LA, Anzueto A, t.et al. (>ui<it*line.s tor tliemanagement of adults with community-acquired pneumonia:diagnosis, assessment of severity, antimicrobial therapy, andprevention [J], American Journal of Respiratory and (Critical Care.*Medicine, 2001, 163(7): 1730-1754.
5American Thoracic Society, Infectious Disease Society ofAmerica. Guidelines for the management of adults withhospital-acquired, ventilator-associated, and healthcare-associatedpneumonia[J]. American Journal of Respiratory and Critical areMedicine, 2005, 171(4): 388-416.
6Restrepo Ml, Anzueto A. Severe coinmunity-acquired pneinnonia[J]. Infectious Disease Clinics of North Aineri<-a, 2009, 23 (3):503-520.
7Mandell LA, Wunderink RG, Anzueto A, el a). InfectiousDiseases Society of America/ American Thoracic Societyconsensus guidelines on the management of community-acquii'edpneumonia in adults [J]. Clinical Infectious Diseases, 2007. 44(Supplement 2): S27-S72.
8Brito V, Niederman MS. How (;an we improve the managementand outcome of pneumonia in the elderly [J]. EuropeanRespiratory Journal, 2008, 32(1):12-14.
9Wunderink RG, Waterer GW. Comniunity-acquired pneumonia[J].New England Journal of Medicine, 2014, 370(6): 543-551.
10Dalhoff A, Petersen U, Endermann R. in vitro activity of K‘\Y12-8039, a new 8-methoxyquinolone [J]. Chemotherapy, 1996, 42(6): 410-425.